The reality check: every single one of these blends is sold strictly for research use only not for human consumption . That label, per Health Canada, does not make these products legal. Youre combining several unapproved compounds with no human trials on the blend itself, from sources with no quality oversight
Injectable Medications: GLP-1 Receptor Agonists and Amylin Analogs In addition to insulin therapy, certain injectable medications may be used as adjunct therapies to improve blood sugar control in individuals with Type 1 Diabetes: GLP-1 Receptor Agonists Glucagon-like peptide-1 (GLP-1) receptor agonists, such as liraglutide (Victoza) and exenatide (Byetta, Bydureon), stimulate insulin secretion, inhibit glucagon release, and delay gastric emptying, resulting in lower blood sugar levels
American Journal Of Clinical Dermatology, 14 (2), 147-153
Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice
But what does that mean, and who needs them